Proteomics International Laboratories Ltd

PIQ.ASX

Health Care

Healthcare and Biotechnology/Life Sciences Tools and Services.

Market Data

Price

$0.135

-0.0%
Market Cap

$22.3M

P/E Ratio

-100000.0x

EPS

$-0.070

Div. Yield

0.00%

52-Week Change

-0.7%

Latest Earnings

Appendix 4D and Interim Financial Report

25 February 2026

Revenue
$0.90
-10.0% YoY
NPAT
-$6.00
+35.0% YoY
EPS
$-0.04

Proteomics International Laboratories reported a significant increase in losses to $6.0M (up 35%) on revenue of $0.9M (down 10%) for the half-year ended December 31, 2025. Despite financial losses, the biotech company achieved key commercial milestones including launching two diagnostic products in Australia and securing US Medicare reimbursement pricing for its lead product Promarker®D, marking its transition from development to early commercialization. Key points: Successful controlled market launches of Promarker®D and Promarker®Eso diagnostic products in Australia; US Medicare reimbursement pricing of ~US$391 established for Promarker®D effective January 2026; Achieved regulated laboratory accreditation across Australia (ISO 15189) and US (CLIA, CAP) creating multijurisdictional platform

Recent Announcements

25 Feb 2026 Actual Results Neutral

Appendix 4D and Interim Financial Report

Proteomics International Laboratories reported a significant increase in losses to $6.0M (up 35%) on revenue of $0.9M (down 10%) for the half-year ended December 31, 2025. Despite financial losses, the biotech company achieved key commercial milestones including launching two diagnostic products in Australia and securing US Medicare reimbursement pricing for its lead product Promarker®D, marking its transition from development to early commercialization. Key points: Successful controlled market launches of Promarker®D and Promarker®Eso diagnostic products in Australia; US Medicare reimbursement pricing of ~US$391 established for Promarker®D effective January 2026; Achieved regulated laboratory accreditation across Australia (ISO 15189) and US (CLIA, CAP) creating multijurisdictional platform

Get real-time alerts for PIQ

Receive AI-powered earnings summaries and instant notifications when Proteomics International Laboratories Ltd releases results.

Register Free